Heres the descriptor exactly as the AMA publishes it, with nothing paraphrased
If You're Waiting for "Legal" Access The July panel is the best signal yet that compounding pharmacy access is coming
Trans Andrology Urol
Documentation and record keeping Treatment log: Date started each peptide, dosing schedule, any modifications, side effects or reactions, concurrent treatments or supplements, costs for insurance or tax purposes
The honest answer is that most of the data on BPC-157 comes from preclinical (animal) studies, with limited but growing human evidence
The collected samples were resuspended in a 0.1% formic acid solution (0.1% formic acid, 2% acetonitrile, and 98% Milli-Q water) and analyzed on an Eksigent C18 column (150 mm 75 m, 3 m) using a gradient mobile phase of 98% acetonitrile, 2% Milli-Q water (A) and 0.1% formic acid (B) at a flow rate of 0.3 L/min